Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

415
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
415
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

370
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
370
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

350
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
350
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

289
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
289
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

237
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
237
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

233
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
233

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive patient education by specialized nurses taking care of patients with heart failure: Results of the EDUSTRA-HF trial on the primary endpoint.

Archives of cardiovascular diseases·2026
Same author

Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study.

The Canadian journal of cardiology·2026
Same author

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Management and outcomes of patients with ST-segment elevation myocardial infarction and large infarct-related arteries.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Effectiveness and Safety of 4-Fr Distal Radial Access With Low-Dose Unfractionated Heparin Versus Proximal Radial Access for Coronary Angiography.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025
Same author

[End for the special CNCH issue of the « Annales de cardiologie et angéiologie ».]

Annales de cardiologie et d'angeiologie·2025

Related Experiment Video

Updated: Dec 25, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.2K

[Takotsubo cardiomyopathy].

Jean-Jacques Dujardin1, Loïc Belle2, Komlavi Yayehd3

  • 1Service de cardiologie, centre hospitalier de Douai, Douai, France.

La Revue Du Praticien
|April 3, 2020
PubMed
Summary
This summary is machine-generated.

Takotsubo cardiomyopathy, a stress-induced heart condition, mimics heart attacks but lacks coronary artery blockages. While often reversible, this transient apical ballooning syndrome can have acute complications and requires psychological support.

Keywords:
Takotsubo cardiomyopathy

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

6.8K

Related Experiment Videos

Last Updated: Dec 25, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.2K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

6.8K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Cardiovascular Diseases

Background:

  • Takotsubo cardiomyopathy, also known as transient apical ballooning syndrome, is a condition affecting the left ventricle.
  • It commonly occurs in postmenopausal women, often triggered by significant mental or physical stress.
  • The condition presents symptoms similar to acute coronary syndrome.

Purpose of the Study:

  • To describe the characteristics, diagnosis, and management of Takotsubo cardiomyopathy.
  • To differentiate Takotsubo cardiomyopathy from acute coronary syndrome.
  • To highlight the importance of supportive care in managing this condition.

Main Methods:

  • Clinical presentation analysis.
  • Electrocardiographic and biological marker evaluation.
  • Coronary angiography to exclude coronary artery occlusion.
  • Echocardiogram, left ventriculography, and cardiac MRI for ventricular assessment.

Main Results:

  • Coronary angiography reveals no coronary occlusion or plaque rupture.
  • Imaging techniques confirm left ventricular deformation and impaired systolic function without myocardial infarction.
  • The condition typically shows recovery of ventricular function over time.

Conclusions:

  • Takotsubo cardiomyopathy is a distinct entity from acute coronary syndrome, characterized by reversible left ventricular dysfunction.
  • While prognosis is generally favorable, acute complications and recurrences are possible.
  • Standardized treatment is lacking, emphasizing the need for psychological care and supportive management.